Chronic insomnia

American Journal of Psychiatry

Volumn 165, Issue 6, 2008, Pages 676-686

  Buysse, Daniel J ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Department of Psychiatry ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESCITALOPRAM; LEVOTHYROXINE; ZOLPIDEM; HYPNOTIC SEDATIVE AGENT; PYRIDINE DERIVATIVE;

ADULT; CASE REPORT; CHRONIC DISEASE; DIVORCE; DRUG INTERMITTENT THERAPY; FEMALE; HUMAN; INSOMNIA; IRRITABILITY; LIFE STRESS; MAJOR DEPRESSION; NIGHT SLEEP; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGIC ASSESSMENT; REVIEW; SOCIAL INTERACTION; THYROID FUNCTION TEST; TREATMENT PLANNING; ANAMNESIS; ARTICLE; BEHAVIOR THERAPY; COMORBIDITY; DIFFERENTIAL DIAGNOSIS; MULTIMODALITY CANCER THERAPY; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT;

ADULT; BEHAVIOR THERAPY; CHRONIC DISEASE; COMBINED MODALITY THERAPY; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MEDICAL HISTORY TAKING; PATIENT EDUCATION AS TOPIC; PYRIDINES; SLEEP INITIATION AND MAINTENANCE DISORDERS;

EID: 44949208772     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.2008.07121943     Document Type: Review

References (41)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed, Text Revision. Washington, DC, American Psychiatric Association, 2000
2. American Academy of Sleep Medicine: The International Classification of Sleep Disorders, 2nd ed: Diagnostic and Coding Manual. Westchester, Ill, American Academy of Sleep Medicine, 2005
3. Hohagen F, Kappler C, Schramm E, Riemann D, Weyerer S: Sleep onset insomnia, sleep maintaining insomnia, and insomnia with early morning awakening: temporal stability of subtypes in a longitudinal study on general practice attenders. Sleep 1994; 17:551-554
4. National Institutes of Health: Drugs and Insomnia: The Use of Medications to Promote Sleep: NIH Consensus Development Conference. National Institutes of Health Consensus Development Conference Summary 1984; 4:1-19
5. National Institutes of Health State of the Science Conference Statement on Manifestations and Management of Chronic Insomnia in Adults, June 13-15, 2005. Sleep 2005; 28:1049-1057
6. Ohayon MM: Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002; 6:97-111
7. Buysse DJ, Germain A, Moul DE: Diagnosis, epidemiology, and consequences of insomnia. Prim Psychiatry 2005; 12:37-44
8. Buysse DJ, Angst J, Gamma A, Ajdacic V, Eich D, Rössler W: Prevalence, course, and comorbidity of insomnia and depression in young adults. Sleep 2008; 31:473-480
9. Foley DJ, Monjan A, Simonsick EM, Wallace RB, Blazer DG: Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years. Sleep 1999; 22(suppl 2):S366-S372
10. Moul DE, Nofzinger EA, Pilkonis PA, Houck PR, Miewald JM, Buysse DJ: Symptom reports in severe chronic insomnia. Sleep 2002; 25:553-563
11. Katz DA, McHorney CA: Clinical correlates of insomnia in patients with chronic illness. Arch Intern Med 1998; 158:1099-1107
12. Perlis ML, Smith LJ, Lyness JM, Matteson SR, Pigeon WR, Jungquist CR, Tu X: Insomnia as a risk factor for onset of depression in the elderly. Behav Sleep Med 2006; 4:104-113
13. Buysse DJ, Tu XM, Cherry CR, Begley AE, Kowalski J, Kupfer DJ, Frank E: Pretreatment REM sleep and subjective sleep quality distinguish depressed psychotherapy remitters and nonremitters. Biol Psychiatry 1999; 45:205-213
14. Nierenberg AA, Keefe BR, Leslie VC, Alpert JE, Pava JA, Worthington JJ, Rosenbaum JF, Fava M: Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999; 60:221-225
15. Reynolds CF III, Frank E, Houck PR, Mazumdar S, Dew MA, Cornes C, Buysse DJ, Begley A, Kupfer DJ: Which elderly patients with remitted depression remain well with continued interpersonal psychotherapy after discontinuation of antidepressant medication? Am J Psychiatry 1997; 154:958-962
16. Buysse DJ, Germain A, Moul D, Nofzinger EA: Insomnia, in Sleep Disorders and Psychiatry. Edited by Buysse DJ. Review of Psychia, vol 24. Arlington, Va, American Psychiatric Publishing, 2005, pp 29-75
17. Spielman AJ, Anderson MW: The clinical interview and treatment planning as a guide to understanding the nature of insomnia: the CCNY Insomnia Interview, in Sleep Disorders Medicine: Basic Science, Technical Considerations, and Clinical Aspects. Edited by Chokroverty S. Boston, Butterworth-Heinemann, 1999, pp 385-416
18. Perlis ML, Smith MT, Pigeon WR: Etiology and pathophysiology of insomnia, in Principles and Practice of Sleep Medicine. Edited by Kryger MH, Roth T, Dement WC. Philadelphia, Elsevier Saunders, 2005, pp 714-725
19. Nofzinger EA, Buysse DJ, Germain A, Price JC, Miewald JM, Kupfer DJ: Functional neuroimaging evidence for hyperarousal in insomnia. Am J Psychiatry 2004; 161:2126-2129
20. Morin CM: Psychological and behavioral treatments for primary insomnia, in Principles and Practice of Sleep Medicine. Edited by Kryger MH, Roth T, Dement WC. Philadelphia, Elsevier Saunders, 2005, pp 726-737
21. Morin CM, Bootzin RR, Buysse DJ, Edinger JD, Espie CA, Lichstein KL: Psychological and behavioral treatment of insomnia: an update of recent evidence (1998-2004). Sleep 2006; 29:1398-1414
22. Glovinsky P, Spielman A: The Insomnia Answer: A Personalized Program for Identifying and Overcoming the Three Types of Insomnia. New York, Perigee Books, 2006
23. Morin CM: Insomnia: Psychological Assessment and Management. New York, Guilford, 1993
24. Morin CM, Espie CA: Insomnia: A Clinical Guide to Assessment and Treatment. New York, Kluwer Academic/Plenum Publishers, 2003
25. Perlis ML, Smith MT, Jungquist C, Posner D: Cognitive Behavioral Treatment of Insomnia: A Session-by-Session Guide. New York, Springer-Verlag, 2005
26. Bateson AN: The benzodiazepine site of the GABAA receptor: an old target with new potential? Sleep Med 2004; 5(suppl 1):S9-S15
27. Drug Facts and Comparisons: Pocket Version 2008. Baltimore, Lippincott Williams & Wilkins, 2007
28. Brunton LL, Lazo JS, Parker KL: Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11th ed. New York, McGraw-Hill, 2006
29. Nowell PD, Mazumdar S, Buysse DJ, Dew MA, Reynolds CF, Kupfer DJ: Benzodiazepines and zolpidem for chronic insomnia: a meta-analysis of treatment efficacy. JAMA 1997; 278:2170-2177
30. Smith MT, Perlis ML, Park A, Smith MS, Pennington J, Giles DE, Buysse DJ: Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry 2002; 159:5-11
31. Walsh JK, Roehrs T, Roth T: Pharmacologic treatment of primary insomnia, in Principles and Practice of Sleep Medicine. Edited by Kryger MH, Roth T, Dement WC. Philadelphia, Elsevier Saunders, 2005, pp 748-760
32. Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T: Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006; 59:1052-1060
33. Dorsey CM, Lee KA, Scharf MB: Effect of zolpidem on sleep in women with perimenopausal and postmenopausal insomnia: a 4-week randomized, multicenter, double-blind, placebo-controlled study. Clin Ther 2004; 26:1578-1586
34. Perlis ML, McCall WV, Krystal AD, Walsh JK: Long-term, non-nightly administration of zolpidem in the treatment of patients with primary insomnia. J Clin Psychiatry 2004; 65:1128-1137
35. Krystal AD, Walsh JK, Laska E, Caron J, Amato DA, Wessel TC, Roth T: Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 2003; 26:793-799
36. Erman M, Seiden D, Zammit G, Sainati S, Zhang J: An efficacy, safety, and dose-response study of ramelteon in patients with chronic primary insomnia. Sleep Med 2006; 7:17-24
37. Taibi DM, Landis CA, Petry H, Vitiello MV: A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med Rev 2007; 11:209-230
38. Morin CM, Wooten V: Psychological and pharmacological approaches to treating insomnia: critical issues in assessing their separate and combined effects. Clin Psychol Rev 1996; 16:521-542
39. Morin CM, Bastien C, Guay B, Radouco-Thomas M, Leblanc J, Vallières A: Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry 2004; 161:332-342
40. Krystal A, Fava M, Rubens R, Wessel T, Caron J, Wilson P, Roth T, McCall WV: Evaluation of eszopiclone discontinuation after cotherapy with fluoxetine for insomnia with coexisting depression. J Clin Sleep Med 2007; 3:48-55
41. Smith MT, Huang MI, Manber R: Cognitive behavior therapy for chronic insomnia occurring within the context of medical and psychiatric disorders. Clin Psychol Rev 2005; 25:559-592